Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.180
-0.040 (-1.24%)
At close: Sep 1, 2026, 4:00 PM EDT
3.150
-0.030 (-0.94%)
After-hours: Sep 1, 2026, 7:59 PM EDT

Myriad Genetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-112.6-365.9-127.3-263.3-112-27.2
Depreciation & Amortization
50.253.761.261.952.762.8
Loss (Gain) From Sale of Assets
------162
Asset Writedown & Restructuring Costs
8.1319.456.6-16.91.8
Stock-Based Compensation
28.735.249.840.738.136.3
Other Operating Activities
8.3-21.35.422.8-18.5-13.9
Change in Accounts Receivable
27.36.2-8.7-12.5-10.3-8.8
Change in Inventory
-3.2-3.2-6.2-1.8-2.91.6
Change in Accounts Payable
-2.1-1.44.7-3.7-3.59.2
Change in Unearned Revenue
------26.6
Change in Income Taxes
12.54.40.50.70.789.9
Change in Other Net Operating Assets
-9.5-25.3-44.744.3-67.555.5
Operating Cash Flow
7.71.8-8.7-110.9-106.318.6
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-15-15.6-19-63.2-45.3-18
Cash Acquisitions
-----57.2-
Divestitures
--8.8--379.1
Sale (Purchase) of Intangibles
-6.9-11.8-10.7-10.1--
Investment in Securities
--9105.225-86.7
Investing Cash Flow
-21.9-27.4-11.931.9-77.5274.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-16512080--
Total Debt Issued
12516512080--
Long-Term Debt Repaid
--80.5-119.5-40--226.4
Total Debt Repaid
-60.1-80.5-119.5-40--226.4
Net Debt Issued (Repaid)
64.984.50.540--226.4
Issuance of Common Stock
3.43.35.9123.66.391.8
Repurchase of Common Stock
-4.8-7.3-13.4-8.8-10.6-11.5
Other Financing Activities
-16.3-16.3-0.4-1.9-3.7-4.5
Financing Cash Flow
47.264.2-7.4152.9-8-150.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.10.8-10.6-0.6-0.6
Net Cash Flow
33.139.4-2974.5-192.4141.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.3-13.8-27.7-174.1-151.60.6
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.91%-1.67%-3.31%-23.11%-22.35%0.09%
Free Cash Flow Per Share
-0.08-0.15-0.31-2.10-1.880.01
Levered Free Cash Flow
18.190.7613.25-59.29-115.71149.49
Unlevered Free Cash Flow
28.447.3315-57.48-113.71153.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.38.41.91.4-4.4
Cash Income Tax Paid
----1.8-85.4
Change in Working Capital
25-19.3-54.427-83.5120.8
SEC Filings: 10-K · 10-Q